CTLA4 and cancer: James Allison and Tasuku Honjo’s discoveries of cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1), respectively, opened new avenues for cancer immunotherapy (29, 30).